Association of deficient type II protein kinase a activity with aberrant nuclear translocation of the RII beta subunit in systemic lupus erythematosus T lymphocytes
N. Mishra et al., Association of deficient type II protein kinase a activity with aberrant nuclear translocation of the RII beta subunit in systemic lupus erythematosus T lymphocytes, J IMMUNOL, 165(5), 2000, pp. 2830-2840
Systemic lupus erythematosus (SLE) is an autoimmune disorder of indetermina
te etiology characterized by abnormal T cell signal transduction and altere
d T cell effector functions, We have previously observed a profound deficie
ncy of total protein kinase A (PKA) phosphotransferase activity in SLE T ce
lls. Here we examined whether reduced total PKA activity In SLE T cells is
in part the result of deficient type II PKA (PKA-II) isozyme activity. The
mean PKA-II activity in SLE T cells was 61% of normal control T cells. The
prevalence of deficient PKA-IZ activity in 35 SLE subjects was 37%, Deficie
nt Isozyme activity was persistent over time and was unrelated to SLE disea
se activity. Reduced PKA-II activity was associated with spontaneous dissoc
iation of the cytosolic RII beta C-2(2) holoenzyme and translocation of the
regulatory (RII beta) subunit from the cytosol to the nucleus, Confocal im
munofluorescence microscopy revealed that the RII beta subunit was present
in similar to 60% of SLE T cell nuclei compared with only 2-3% of normal an
d disease controls, Quantification of nuclear RII beta subunit protein cont
ent by immunoprecipitation and immunoblotting demonstrated a 54% increase o
ver normal T cell nuclei, Moreover, the RII beta subunit was retained in SL
E T cell nuclei, failed to relocate to the cytosol, and was associated with
a persistent deficiency of PKA-II activity, In conclusion, we describe a n
ovel mechanism of deficient PKA-II isozyme activity due to aberrant nuclear
translocation of the RII beta subunit and its retention in the nucleus in
SLE T cells. Deficient PKA-II activity may contribute to impaired signaling
in SLE T cells.